| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |